Liminatus Pharma, Inc. Class A Common Stock (LIMN)
search
Earnings reactions
How LIMN moved on each past earnings report.
Up
Down
Earnings Impact
Liminatus Pharma, Inc. Class A Common Stock (LIMN) has no earnings-reaction history on record — it does not report quarterly earnings (e.g. a fund, ETF, or other instrument), or is too newly listed to have a track record yet.
Historical Earnings Statistics
Liminatus Pharma, Inc. Class A Common Stock (LIMN) has no earnings-reaction history on record — it does not report quarterly earnings (e.g. a fund, ETF, or other instrument), or is too newly listed to have a track record yet.
event
Earnings Count
0
Total earnings in dataset
trending_up
Avg Abs. Movement
±0.00%
Avg % price change on earnings
account_balance
View all 3 →
Institutional ownership
Holdings as of Mar 31, 2026 · SEC 13-F
3
Funds holding
$5545
Total value held
Flat
1 added · 1 reduced
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| SCHEDULE 13G | 20260722 | open_in_new SEC.gov |
| 4 | 20260714 | open_in_new SEC.gov |
| SCHEDULE 13D/A | 20260714 | open_in_new SEC.gov |
| DEF 14A | 20260713 | open_in_new SEC.gov |
| 3 | 20260706 | open_in_new SEC.gov |
| 4 | 20260706 | open_in_new SEC.gov |
| 8-K | 20260706 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260706 | open_in_new SEC.gov |
| PRE 14A | 20260630 | open_in_new SEC.gov |
| S-1 | 20260624 | open_in_new SEC.gov |